Connectivity-guided theta-burst stimulation targeting the hippocampus in schizophrenia
Official title: Theta Burst Modulation of Hippocampal-Cortical Rhythms in Schizophrenia
Run by Stanford University · NCT07010614 · Data updated 2026-11-12
We will try targeted theta-burst TMS guided by brain connectivity to change hippocampus activity in adults with schizophrenia or related psychotic disorders, measuring brain signals with EEG and, for some participants, intracranial electrodes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Stanford University Academic / other |
| Locations | 1 site (Stanford, California) |
| Status | Recruiting |
| Started | October 1, 2025 |
| Main results expected | September 30, 2027 |
| Study ends | September 30, 2027 |
| Registry record updated | February 27, 2026 |
| Trial ID | NCT07010614 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18–65 with a DSM-5 schizophrenia-spectrum diagnosis for the noninvasive TMS-EEG arms, and adults with medically intractable epilepsy undergoing phase II intracranial EEG monitoring for the intracranial arms.
✕Probably not a fit
People with intellectual disability, recent serious suicidal ideation or attempts, significant head injury or other uncontrolled neurological/medical conditions, pregnancy or inability to consent are unlikely to be eligible or to receive benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This protocol uses connectivity-guided theta-burst transcranial magnetic stimulation (TBS) to target hippocampal networks implicated in schizophrenia. Non-invasive arms receive TMS with concurrent EEG and sham control to record immediate neural responses, while a separate intracranial arm enrolls patients undergoing phase II intracranial EEG monitoring for direct hippocampal recordings. Researchers will compare brain activity before and after stimulation to determine whether hippocampal function can be systematically modulated. Results are intended to clarify hippocampal contributions to symptoms and to inform future neuromodulation treatments.
Why it matters
Potential benefit: If successful, this approach could provide a noninvasive way to alter hippocampal activity and potentially reduce symptoms or cognitive deficits in schizophrenia.
How similar studies have gone: Related connectivity-guided TMS and theta-burst protocols have shown promise in modulating cortical networks and memory in other populations, but hippocampal targeting in schizophrenia remains largely novel and unproven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and women, ages 18 to 65 years * Medically intractable epilepsy requiring phase II monitoring (intracranial EEG arms only) * DSM-V diagnosis of schizophrenia spectrum Axis I disorders including delusional disorder, brief psychotic disorder, schizophreniform disorder, schizophrenia, schizoaffective disorder (non-invasive TMS-EEG arms only). * Must have intellectual capacity to ensure adequate comprehension of the study and potential risks involved in order to provide informed consent * No current or history of major neurological disorders other than epilepsy. Exclusion Criteria: * DSM5 diagnosis of intellectual disability * Significant head injury * Active suicidal ideation or history of suicide attempt within the past 1 year. * Medical illness affecting brain structure or function, or other uncontrolled or unstable medical condition. * Pregnancy or postpartum (\<6 weeks after delivery or miscarriage) * Inability to provide informed consent * Active substance abuse other than alcohol or cannabis within the past 1 year * Psychotic illness with a temporal relation to substance use or head injury * Those with a contraindication for MRIs or TMS (e.g. implanted metal).
Where it's running
-
Stanford University
Stanford, California, United States Recruiting
Study contacts
- Principal investigator: Ethan A Solomon, MD, PhD — Stanford University
- Study coordinator: Study Team
- Email: kellerlab@stanford.edu
- Phone: 408-840-3313
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
iTEST: a blended mobile program to improve introspective accuracy (accurate self-judgment of abilities)
This trial tests whether iTEST — daily mobile cognitive training plus coaching that focuses on accurate self-judgment — helps adults with schizophrenia-spectrum or other psychotic disorders improve community functioning.
-
Transition Support for First-Episode Psychosis
A team-based program helps people experiencing their first psychotic episode move from hospital to outpatient care to see if they stay engaged and feel better.
-
SEEG-guided DBS for Schizophrenia
This study tests whether SEEG-guided deep brain stimulation can help people with treatment-resistant schizophrenia see if symptoms improve.
-
Virtual approaches for period pain in young women
This study tests two online self-care options—auricular acupressure and Baduanjin qigong—against a self-care education group to see if they reduce menstrual pain and related symptoms in young women.
-
Using an epigenetic drug to boost virtual reality cognitive training for middle-aged and older adults with depression or bipolar disorder
This trial will test whether daily sodium butyrate combined with three weeks of virtual reality cognitive training improves thinking skills in symptomatically stable adults aged 40–75 with depression or bipolar disorder.
-
Medical and psychiatric profiling of adults admitted to general adult psychiatry wards
This project will collect questionnaires, rating scales, and case-note information from adults admitted to general adult psychiatry wards to see what their physical and mental health profiles look like.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.